All lobbying filings
Novavax, Inc.
Novavax, Inc. filed a Q2 report for Novavax, Inc. on July 21, 2025.
Lobbying for Novavax, Inc.
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Expenses
$190,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Maryland
Government bodies contacted
4
Lobbying activity
1
Issues related to COVID-19 vaccines, federal vaccine programs, and vaccine regulatory frameworks Reauthorization of Pandemic and All-Hazards Preparedness Act